Seizure control after epilepsy surgery in early childhood: A systematic review and meta-analysis

Hua Li1, Shuming Ji2, Bosi Dong1

  • 1Department of Neurology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan 610041, China.

Epilepsy & Behavior : E&B
|November 3, 2021
PubMed

Insights

Epilepsy surgery outcomes in young children depend on the cause and location of the epilepsy. Identifying the epilepsy

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Refractory epilepsy in children under three years old presents significant challenges.
  • Surgical intervention is considered for severe cases, but outcomes vary.
  • Understanding factors influencing surgical success is crucial for optimizing treatment.

Purpose of the Study:

  • To conduct a meta-analysis identifying key factors affecting surgical outcomes in infants and children under three years with refractory epilepsy.
  • To evaluate the impact of specific variables such as etiology, age, and surgical approach on seizure control.

Main Methods:

  • Systematic literature search of PubMed and Cochrane databases (1991-2021).
  • Inclusion of 32 studies encompassing 559 pediatric cases.
  • Meta-analysis using fixed-effects models to assess the influence of seizure onset, epilepsy duration, MRI findings, age, surgical methods, resection extent, and pathology on seizure outcomes.

Main Results:

  • Frontal lobectomy and malformation of cortical development (MCD) were associated with lower seizure control rates (OR 0.33 and 0.38, respectively).
  • Children with tumors (92.86%) and Sturge-Weber syndrome (SWS) (91.43%) showed higher seizure control rates.
  • Frontal lobe epilepsy secondary to MCD demonstrated the poorest postoperative efficacy (OR 0.26).

Conclusions:

  • Pathology and surgical site are critical determinants of epilepsy surgery outcomes in very young children.
  • Preoperative clarification of epilepsy etiology is essential for improving postoperative results.
  • Further research into specific etiologies and surgical techniques may enhance treatment strategies.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
359
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
675
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
519
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
260